Abstract:Background Adventitial remodeling is a pathological hallmark of hypertension that results in target organ damage. Activated adventitial fibroblasts have emerged as critical regulators in this process, but the precise mechanism remains unclear. Methods and Results Interleukin 11 (IL‐11) knockout and wild‐type mice were subjected to angiotensin II (Ang II) infusion to establish models of hypertension‐associated vascular remodeling. IL‐11 mRNA and protein were increased especially in the adventitia in response to Ang II. Compared with wild‐type mice, Ang II–treated IL‐11 knockout mice showed amelioration of vascular hypertrophy, adventitial fibrosis, macrophage infiltration, and inflammatory factor expression. Recombination mouse IL‐11 exacerbated adventitial fibrosis in Ang II–infused wild‐type mice. Interestingly, IL‐11 neutralizing antibody attenuated adventitial fibrosis, macrophage infiltration, and inflammatory factor expression after Ang II infusion for 7 days. Mechanistically, in primary cultured adventitial fibroblasts, Krüppel‐like factor 15 negatively regulated Ang II–induced IL‐11 expression. Ang II increased extracellular signal‐regulated kinases 1 and 2 activation, especially in adventitia, and caused biphasic extracellular signal‐regulated kinases 1 and 2 activation in adventitial fibroblasts. A rapid and early activation increased IL‐11 production through decreasing Krüppel‐like factor 15 expression, which, in turn, induced the second extracellular signal‐regulated kinases 1 and 2 activation, resulting in posttranscriptional profibrotic gene expression. Conclusions These results demonstrate that extracellular signal‐regulated kinases 1 and 2 activation is important for Krüppel‐like factor 15–mediated IL‐11 expression in adventitial fibroblasts to promote adventitial remodeling in Ang II–induced hypertension. Therefore, targeting the Krüppel‐like factor 15/IL‐11 axis might serve as a new therapeutic strategy for vascular diseases. Nonstandard Abbreviations and Acronyms ACTA α‐smooth muscle actin AF adventitial fibroblast Ang II angiotensin II COL1a1 collagen, type I, α 1 IL‐11 –/– interleukin 11 knockout KLF15 Krüppel‐like factor 15 rmIL‐11 recombination mouse IL‐11 WT wild type Clinical Perspective What Is New? Blockade of interleukin 11 (IL‐11) almost normalized adventitial fibrosis induced by angiotensin II. Krüppel‐like factor 15 negatively regulates IL‐11 expression, depending on extracellular signal‐regulated kinases 1 and 2 activation, which contributed to adventitial remodeling. Angiotensin II induced biphasic extracellular signal‐regulated kinases 1 and 2 activation with the second activation depending on IL‐11. What Are the Clinical Implications? Our study reveals a novel role for IL‐11 in hypertension‐associated vascular remodeling and fibrosis. We provide a possible treatment strategy for Krüppel‐like factor 15/IL‐11 axis in alleviating and reversing hypertension‐associated vascular remodeling and fibrosis. Vascular remodeling is a common consequence of hypertensive disease and contributes to the development of cardiovascular dysfunction. 1 The vessel wall is a multilayered tissue consisting of multiple cell types to regulate vascular remodeling. Rather than a supportive tissue layer, growing evidence has shown that vascular adventitia acts as an active player for maintenance of vascular function and homeostasis. 2 Indeed, excessive adventitial remodeling leads to early aortic maladaptation in angiotensin II (Ang II)–induced hypertension. 3 The main effector cells of adventitia are adventitial fibroblasts (AFs), which are activated by stress signals in injured tissues. -Abstract Truncated-

Krüppel-Like Factor 15 Modulates CXCL1/CXCR2 Signaling-Mediated Inflammatory Response Contributing to Angiotensin II-Induced Cardiac Remodeling

Dectin-1 Acts As a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.

C-Reactive Protein Promotes Cardiac Inflammation and Fibrosis in Angiotensin Ii-Induced Hypertensive Cardiovascular Diseases

Kruppel Like Factor 15 Attenuates Activation Of Adventitial Fibroblasts-Mediated Angiotensin Ii-Induced Vascular Remodeling

Transactivation Domain of Krüppel‐like Factor 15 Negatively Regulates Angiotensin II–induced Adventitial Inflammation and Fibrosis

Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling

The Kruppel-Like Factor Klf15 Inhibits Connective Tissue Growth Factor (Ctgf) Expression In Cardiac Fibroblasts.

CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration

KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression

Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1–Endothelin-1 Signal Pathway

Krüppel-like Factor 4 Transcriptionally Regulates TGF-β1 and Contributes to Cardiac Myofibroblast Differentiation.

The role of IL15 in angiotensin II-mediated cardiac remodelling

Endothelial Klf2-Foxp1-TGF signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling

Krüppel-Like Factor 15/Interleukin 11 Axis-Mediated Adventitial Remodeling Depends on Extracellular Signal-Regulated Kinases 1 and 2 Activation in Angiotensin II-Induced Hypertension.

CCL24/CCR3 Axis Plays a Central Role in Angiotensin II–induced Heart Failure by Stimulating M2 Macrophage Polarization and Fibroblast Activation

Endothelial S1pr1 Regulates Pressure Overload‐induced Cardiac Remodelling Through AKT‐eNOS Pathway

KLF2 Regulates Neutrophil Activation and Thrombosis in Cardiac Hypertrophy and Heart Failure Progression

C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload

KLF4 in smooth muscle cell-derived progenitor cells is essential for angiotensin II-induced cardiac inflammation and fibrosis

Activated FMS‐like Tyrosine Kinase 3 Ameliorates Angiotensin II‐induced Cardiac Remodelling

Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling